Send Inquiry

Request To Call Back

Fludarabine Phosphate Injection

Get a Price/Quote

MOQ : 100 Boxes

Fludarabine Phosphate Injection Specification

Indication
Chronic lymphocytic leukemia; can also treat indolent non-Hodgkin lymphoma and acute leukemias

Origin of Medicine
India

Packaging Type
Glass vial

Dosage Form
Injection

Life Span
2 years from the date of manufacture

Pacakaging (Quantity Per Box)
1 vial per box

Salt Composition
Fludarabine Phosphate 50 mg/2 mL

Brand Name
Varies (pharmaceutical manufacturer specific)

Drug Type
Allopathic

Ingredients
Fludarabine Phosphate

Physical Form
Liquid

Function

Recommended For
Anti-cancer treatment; mainly for chronic lymphocytic leukemia (CLL)

Dosage
As directed by the physician; dosage varies by indication and patient condition

Dosage Guidelines
Administer intravenously under medical supervision only

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store in a refrigerator (2C - 8C); do not freeze

Usage
Hospital use only, by oncology professionals

Contraindications
Hypersensitivity to fludarabine phosphate or any excipients; severe renal impairment

Interaction With Other Drugs
May interact with pentostatin, cytarabine, and other immunosuppressive agents

Appearance
Clear, colorless to slightly yellow solution

Shelf Life
24 months from date of manufacture

Route of Administration
Intravenous infusion

Handling Precautions
Cytotoxic; handle with appropriate safety measures

Side Effects
Myelosuppression, nausea, vomiting, fever, infections, neurotoxicity

Prescription Required
Yes

Disposal
Dispose as per local cytotoxic waste guidelines

Strength
50 mg/2 mL

Fludarabine Phosphate Injection Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Fludarabine Phosphate Injection

Experience the latest innovation in anti-cancer therapy with Fludarabine Phosphate Injection, a first-rate solution trusted by oncology professionals. This fresh, clear, colorless to slightly yellow liquid is formulated for hospital use, offering a dominant treatment option for chronic lymphocytic leukemia, indolent non-Hodgkin lymphoma, and acute leukemias. Supplied in a special glass vial, each dose contains a valuable 50 mg/2 mL Fludarabine Phosphate, designed for intravenous infusion. With precise dosage and advanced handling guidelines, it is a prescription-required, hospital-only, allopathic medication from India. Store refrigerated for up to two years, ensuring consistent, high-quality administration.

Versatile Application in Oncology Facilities

Fludarabine Phosphate Injection is a dominant choice for oncology centers, with broad plant and clinical application. It is primarily used in hospital settings for treating conditions like chronic lymphocytic leukemia, indolent non-Hodgkin lymphoma, and acute leukemias. The main advantage lies in its valuable efficacy against these hard-to-treat cancers, offering improved patient outcomes when administered by professional healthcare providers. Efficient dosage flexibility allows tailored treatment, maximizing therapeutic benefits and minimizing risks.

Reliable Supply and Export Coverage

Stock is ready for prompt dispatch, ensuring consistent supply for domestic and global healthcare institutions. Our supply chain leverages efficient freight and transportation networks, enabling timely delivery to major export markets and robust distribution within India's key healthcare regions. Customers benefit from dependable packing, one vial per box, and strict adherence to cold-chain protocols that preserve the medication's first-rate quality until it reaches the point of use.

FAQ's of Fludarabine Phosphate Injection:

Q: How should Fludarabine Phosphate Injection be administered?

A: Fludarabine Phosphate Injection must be administered intravenously by trained oncology professionals in a hospital setting. Dosage and schedule will be determined by a physician based on patient-specific factors and treatment indication.

Q: What are the main uses of Fludarabine Phosphate Injection?

A: This medication is primarily indicated for chronic lymphocytic leukemia but can also treat indolent non-Hodgkin lymphoma and acute leukemias, making it a valuable option for various hematologic malignancies.

Q: When should Fludarabine Phosphate Injection not be used?

A: It should not be used in patients with known hypersensitivity to fludarabine phosphate or any excipients, nor in those with severe renal impairment, as per the contraindications outlined.

Q: What handling precautions are necessary for this product?

A: As a cytotoxic agent, Fludarabine Phosphate Injection requires handling with appropriate safety measures, including gloves and protective gear. Disposal must follow local cytotoxic waste regulations to ensure the safety of healthcare personnel and the environment.

Q: Where should Fludarabine Phosphate Injection be stored?

A: This injection must be stored in a refrigerator at temperatures between 2C and 8C. Avoid freezing, and always monitor storage conditions to preserve product efficacy until administration.

Q: What are the potential drug interactions of Fludarabine Phosphate Injection?

A: It may interact with drugs like pentostatin, cytarabine, and other immunosuppressive agents. Always inform your healthcare provider of any medications you are taking to avoid adverse interactions.

Tell us about your requirement